{"result": {"id": "chatcmpl-654", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "The **OS** (Median Overall Survival) is a crucial measure of survival time for patients with Epithelial Ovarian Cancer (EOC), representing the average length of time individuals survive after diagnosis and treatment. It can be further broken down into \"Overall Survival\" or \"Overall survival in patients with EOC.\"  \n\nThe **Oncology Study (OS)** encompasses both the broader field of Oncology and the specific metric, **OS**, which stands for **Oncology Study**. Within this field, there are two types of **OS**: \n* **Osteosarcoma (OS)** is a type of cancer characterized by low expression of miR-877-3p.  \n* **Objective Survival (OS)** is an outcome measure used to assess the overall survival of patients with a specific condition or disease, representing the time it takes for a group of individuals to die and often used as a primary indicator of treatment effectiveness in cancer research. This metric can also be referred to as \"Overall Survival\" or \"Outcome measure for patients.\" \n\n\n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743241007, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 212, "prompt_tokens": 416, "total_tokens": 628, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are a helpful assistant responsible for generating a comprehensive summary of the data provided below.\nGiven one or two entities, and a list of descriptions, all related to the same entity or group of entities.\nPlease concatenate all of these into a single, comprehensive description. Make sure to include information collected from all the descriptions.\nIf the provided descriptions are contradictory, please resolve the contradictions and provide a single, coherent summary.\nMake sure it is written in third person, and include the entity names so we have the full context.\n\n#######\n-Data-\nEntities: \"OS\"\nDescription List: [\"The **OS** (Median Overall Survival) refers to the duration of life for patients after receiving treatment, specifically within the context of  patients with Epithelial Ovarian Cancer (EOC). It is a crucial measure of survival time and represents the average length of time individuals survive after diagnosis and treatment. The OS can be further broken down into \\\"Overall Survival\\\" or \\\"Overall survival in patients with EOC,\\\" indicating its application to specific patient groups. \\n\", \"The **Oncology Study (OS)** is a field of study focused on the human body and its response to cancer treatment, encompassing various approaches to treating cancer.  It encompasses both **Oncology** as a broader field and **OS**, which stands for **Oncology Study**. \\n\\nWithin this field, there are two specific types of **OS**: **Osteosarcoma (OS)** is a type of cancer characterized by low expression of miR-877-3p.  The **OS** (Objective Survival) is an outcome measure used to assess the overall survival of patients with a specific condition or disease. It represents the time it takes for a group of individuals to die, and is often used as a primary indicator of treatment effectiveness in cancer research. This metric can also be referred to as \\\"Overall Survival\\\" or \\\"Outcome measure for patients.\\\" \\n\\n\\n\"]\n#######\nOutput:\n", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 500, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_summarize_c28bb8b5909b02aa1cb8f9a12ace1f33d713f35ae83d43d0c7026ba65c1ffbde_v2"}